Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Formula Pharmaceuticals
Berwyn, Pennsylvania, United Statesformulapharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Formula Pharmaceuticals developed an allogeneic, non-viral CAR-CIK cell therapy platform for oncology and autoimmune diseases. Technology was merged into CoImmune in 2020; programs remain preclinical with plans for clinical development in acute lymphoblastic leukemia.[1][2][3][5]
- Therapeutic areas
- OncologyHematology
- Modalities
- CAR-CIKCell therapy
- Industry
- Biotech
02
Partnerships
Max Delbrück Center for Molecular Medicine (MDC)Tettamanti FoundationSan Gerardo Hospital
Beyond the preview
Go deeper on Formula Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Formula Pharmaceuticals.